Stability Testing and Forced Degradation Studies for Pharmaceuticals
Keep your pharmaceutical development on track with integrated stability storage and testing in FDA-registered and inspected facilities, where samples remain under ICH-compliant environmental monitoring from storage through analysis. Generate stability-indicating data for regulatory submissions, supported by specialized storage conditions, validated analytical methods, and comprehensive testing capabilities across Element’s North American laboratories.

What is Stability Testing and Forced Degradation Studies for Pharmaceuticals at Element?
Stability testing evaluates pharmaceutical product quality over time under varying environmental conditions. Forced degradation studies provide a valuable tool to evaluate drug substance stability and understand its potential impact on potency, purity, and patient safety. The impurity profile of an API or drug substance stressed under various conditions informs analytical method development, product packaging, shipping, aids in defining specifications, and assists in formulating stable dosage forms.
Element's comprehensive analytical services track product performance, identifying critical quality attributes and potential degradation pathways throughout the entire development lifecycle. Our stability storage and testing programs provide robust data you need to support your CMC strategy and regulatory submission, ensuring consistent product quality from early development through commercialization.

What Can Element Offer You For Stability Testing and Forced Degradation Studies?
Products and materials we test
Products and materials we test
Element provides comprehensive stability testing that addresses pharmaceutical product development challenges across the entire lifecycle, from preclinical stages through clinical trials and post-approval studies. Our analytical experts deliver robust testing programs that generate high-quality data to support development milestones while meeting regulatory requirements, covering pharmaceutical drug substances and products, various dosage forms, including oral solids, parenterals, and topical products.
Key tests offered
Key tests offered
- ICH stability testing services across standard conditions
- Real-time and long-term stability under controlled conditions
- Accelerated stability programs
- In-use studies and beyond-use stability
- Photostability testing to ICH guidelines
- Formulation evaluation stability
- Follow-up stability testing
- Freeze-thaw stability studies
- Stability-indicating assay development
- Stress stability testing
- R&D stability testing
- Identification of unknown degradants and impurities
- Registration batch stability testing
- Finished product release
- Sterility and microbiological assessment
- Container-closure integrity testing
- Protocol design for degradation studies defined by leading chemists
- Identification of degradation products using advanced analytical techniques
- Proven track record developing stability-indicating assays based on degradation data
- Comprehensive reports
- Development of stability-indicating analytical methods
- Identification of unknown degradants and impurities
- Specialized analytical techniques for precise product characterization
- Comprehensive quality attribute evaluation
- Support for multiple regulatory submission pathways
- Customized analytical strategies for unique product formulations
- HPLC and UPLC for detection of degradants and impurities
- LC-MS/MS for identification of degradants and impurities
- GC-MS for volatile compounds and residual solvents
- Pharmaceutical X-Ray Diffraction (XRD) for material characterization
- FTIR and micro FTIR for structural characterization
- Karl Fischer for moisture determination
- Dissolution testing
- Ion chromatography
- Compendial testing (USP, EP, JP)
- Cryogenic freezers (< -130°C)
- Ultralow temperature (<-60°C)
- Frozen (-20°C)
- Refrigerated (2-8°C)
- Standard ICH conditions: 25°C/60% RH, 30°C/65% RH, 40°C/75% RH
- Ambient (30°C)
- Custom conditions based on availability
- 505(b)(1) Investigational New Drug (IND) application
- 505(b)(2) New Chemical Entity (NCE) pathway
- 505(j) Abbreviated New Drug Application (ANDA) for generic drugs
- NDA (New Drug Application)
- OTC (Monograph-based or IND-based)
Cutting-edge equipment we use
Cutting-edge equipment we use
- Advanced stability chambers with 24/7 automated monitoring
- Backup generators ensuring continuous operation
- Multiple storage condition chambers with precise environmental control
- Specialized instrumentation for pharmaceutical analysis
- Advanced chromatography systems (HPLC, UPLC, GC-MS)
- Sophisticated spectrophotometry and spectroscopy instrumentation
- State-of-the-art mass spectrometry, including Quadrupole/Time of Flight tandem mass spectroscopy (Q-TOF)
- 500 MHz Nuclear Magnetic Resonance (NMR) equipment for structural characterization
- Dynamic light scattering for specialized applications
- Specialized analytical tools for pharmaceutical characterization
Which labs offer this service
Which labs offer this service
Integrated Storage and Testing Solutions
Integrated Storage and Testing Solutions
Element's laboratories house both stability storage and analytical testing in the same facility, eliminating the coordination challenges that occur when managing separate vendors. Your samples remain under continuous ICH-compliant environmental control from storage pull through analysis, while scientists who understand both environmental parameters and analytical methods can address questions immediately when results require interpretation. Comprehensive stability testing programs generate precise, reliable data across various drug development stages, meeting specific regulatory and scientific requirements for your submissions.
Standards we test to and products we test
- FDA Regulatory Standards for stability testing
- USP Compendial Standards
- EP (European Pharmacopoeia) Standards
- JP (Japanese Pharmacopoeia) Standards
- Active pharmaceutical ingredients (API)
- Drug intermediates
- Reference standards
- Oral solid dosage forms (tablets, capsules, etc.)
- Parenteral medications (injectables, infusions, lyophilized products)
- Topical formulations (creams, ointments, gels, lotions)
- Transdermal patches
- Ophthalmic preparations
- Nasal sprays
- Inhalation products
- Generic pharmaceutical products
- Over-the-counter (OTC) medications
- Combination products
Your Challenges, Our Solutions
Navigating complex regulatory requirements
Ensuring consistent product quality
Managing specialized testing requirements
Understanding degradation behavior
Why Choose Element

Integrated Storage and Testing
Multiple North American Locations
Comprehensive Analytical Capabilities
Regulatory-Compliant Testing
Element Experts at your Service
Frequently asked questions
What regulatory pathways can Element support?
Element supports multiple regulatory pathways including IND applications for clinical investigation, ANDA submissions for generic drugs, and NDA filings for new molecular entities. The stability data generated follows ICH guidelines and addresses Chemistry, Manufacturing, and Controls (CMC) section requirements across these submission types, with testing protocols designed to meet specific reviewer expectations for each pathway.
How do stability-indicating methods differ from standard analytical methods?
Stability-indicating methods are specifically designed and validated to detect and quantify degradation products from the active pharmaceutical ingredient, even when multiple degradants form under stress conditions. Standard analytical methods might detect the API but miss critical impurities that develop during storage. A properly validated stability-indicating method demonstrates specificity for the drug substance in the presence of its degradation products, providing confidence that your analytical data accurately reflects product quality throughout shelf life rather than masking degradation behind unchanged API peaks.
What is forced degradation and why is it important?
Forced degradation involves exposing drug substances to stress conditions like heat, light, oxidation, reducing conditions, acid/base hydrolysis, and agitation to intentionally degrade the molecule and identify potential degradation pathways. This reveals how your product might degrade under real-world conditions, which pathways are most likely, and what degradants to monitor. Understanding degradation behavior early informs several critical decisions: which analytical methods can adequately separate and quantify degradants, what storage conditions protect product quality, which packaging materials prevent degradation, and what specifications appropriately control quality attributes throughout the proposed shelf life.
How does integrated storage and testing benefit my stability program?
Integrated storage and testing within FDA-registered facilities eliminates coordination delays and sample transfer risks that occur when managing separate vendors. Samples remain under continuous ICH-compliant environmental control from storage pull through analysis, while scientists who understand both environmental parameters and analytical methods can address questions immediately when results require interpretation. This integration proves valuable when analytical results raise questions about storage conditions or degradation behavior, as answers come from the same team managing both aspects of your program.

Explore our global network of labs and find your nearest location
VIEW ALL LOCATIONSRelated services

Analytical Method Development & Validation
Element's regulatory and industry experts have a proven track record of successfully developing and validating fit-for-purpose, accurate, and reliable analytical methods based on established CDER/ICH and FDA guidelines and procedures.

Chemistry, Manufacturing and Controls (CMC) & CDMO Testing Services
Element provides specialized analytical testing services designed for CDMOs, offering flexible capacity, regulatory compliance, and advanced capabilities that enable successful client program delivery across all development phases.

Pharmaceutical Quality Control Testing
Element provides pharmaceutical quality control testing, covering raw materials, APIs, and finished products. Our expert analytical development and validation help meet regulatory requirements and support all phases of product development.

Extractables and Leachables Testing Services
Element provides tailored extractables and leachables testing (E&L) studies to ensure patient safety and compliance with regulatory requirements.

Pharmaceutical Testing Services
Element leads the way in pharmaceutical testing services, delivering trusted expertise from prototype to analysis and finished product. With 150+ global pharmaceutical experts and 30+ years of experience.


